For example, the PIK3CA mutation c.3140A>G (p.His1047Arg) identified in this study is one of the most frequently reported mutations in endometrial cancer and has been extensively documented as a driver of the PI3K/AKT pathway, contributing to tumorigenesis and cancer progression [11]. This evidence concerns the gene PIK3CA and endometrial cancer.